Pharmacogenomics Education Program

PharmGenEd™ Asthma

KuoOffice — Mon, 08 Nov 2010 15:47:27 -0800

This webinar was presented on Tuesday, November 2, 2010 by Dr. Alice Gardner. Dr. Gardner discusses select pharmacogenomic effects in patients with asthma.

Safe and Effective Medication Therapy Management

PharmGenEd™ Psychiatry I: Depression

KuoOffice — Fri, 22 Oct 2010 15:26:33 -0700

This webinar was presented on Thursday, October 21, 2010 by Dr. Vicki Ellingrod. Dr. Ellingrod discusses select pharmacogenomic effects in patients treated with antidepressant medications.

Safe and Effective Medication Therapy Management

PharmGenEd™ Economic Issues

KuoOffice — Wed, 13 Oct 2010 09:54:04 -0700

This webinar was presented on Tuesday, October 12, 2010 by Dr. Louis Garrison and Dr. David Veenstra. Dr. Garrison and Dr. Veenstra discuss economic issues relating to pharmacogenomics.

Safe and Effective Medication Therapy Management

PharmGenEd™: Train-the-Trainer for Healthcare Practitioners Q&A Session

KuoOffice — Thu, 23 Sep 2010 16:17:09 -0700

Part 2 of 2 is the Question and Answer session regarding Train-the-Trainer for Healthcare Practitioners where Director, PharmGenEd™ Training for Healthcare Practitioners, Joseph Ma, PharmD discusses past questions and answers.

Safe and Effective Medication Therapy Management

PharmGenEd™ Cardiology I: Warfarin and Statins

KuoOffice — Thu, 23 Sep 2010 16:13:58 -0700

This webinar was presented on Tuesday, September 21, 2010 by Dr. Jaekyu Shin and Dr. Larisa Cavallari. Dr. Shin and Dr. Cavallari discuss select pharmacogenomic effects of warfarin and statins.

Safe and Effective Medication Therapy Management

PharmGenEd™ Cardiology II: Clopidogrel and Beta Blocker

KuoOffice — Thu, 23 Sep 2010 15:59:00 -0700

This webinar was presented on Thursday, September 23, 2010 by Dr. Larisa Cavallari and Dr. Jaekyu Shin. Dr. Cavallari and Dr. Shin discuss select pharmacogenomic effects of clopidogrel and beta blockers.

Safe and Effective Medication Therapy Management

PharmGenEd™: Train-the-Trainer for Healthcare Practitioners

KuoOffice — Tue, 21 Sep 2010 11:41:16 -0700

Part 1 of 2 is the content section where Director, PharmGenEd™ Training for Healthcare Practitioners, Joseph Ma, PharmD focuses on content material for Pharmacogenomics Principles and Concepts (Module I) and Clinical Applications of Pharmacogenomics (Module II), in addition to discussing program logistics and implementation.

Safe and Effective Medication Therapy Management

PharmGenEd™ Oncology I: Solid Tumors

KuoOffice — Thu, 26 Aug 2010 13:13:14 -0700

This webinar was presented on Thursday, August 26, 2010 by Dr. John M. Valgus. Dr. Valgus discusses select pharmacogenomic effects in patients with solid tumors.

Safe and Effective Medication Therapy Management

PharmGenEd™: Psychiatry II: Antipsychotics

KuoOffice — Thu, 26 Aug 2010 12:52:51 -0700

This webinar was presented on Tuesday, August 24, 2010 by Dr. Jeffrey R. Bishop. Dr. Bishop discusses select pharmacogenomic effects in patients treated with antipsychotic medications.

Safe and Effective Medication Therapy Management

PharmGenEd™ Concepts and Clinical Applications

KuoOffice — Mon, 16 Aug 2010 13:47:44 -0700

This webinar was recorded on Wednesday, August 11, 2010 by Dr. Grace Kuo, Dr. Joseph Ma, and Dr. Kelly Lee discussing the translation of pharmacogenomics into practice, pharmacogenomic nomenclature, examples of the therapeutic area: infectious diseases as well as ethical, legal, social (ELSI) and economic issues.

Safe and Effective Medication Therapy Management

PharmGenEd™ Oncology II: Hematologic Malignancies

KuoOffice — Thu, 12 Aug 2010 15:19:23 -0700

This webinar was presented on Tuesday, August 16, 2010 by Dr. Amy Hatfield Seung. Dr. Seung discusses select pharmacogenomic effects in patients with hematologic malignancies.

Safe and Effective Medication Therapy Management

Module II - Section 5

KuoOffice — Wed, 26 May 2010 13:07:32 -0700

Key Therapeutic Area: Psychiatry
http://pharmacogenomics.ucsd.edu

Safe and Effective Medication Therapy Management

Module II - Section 4

KuoOffice — Wed, 26 May 2010 13:05:06 -0700

Key Therapeutic Area: Neurology
http://pharmacogenomics.ucsd.edu/

Safe and Effective Medication Therapy Management

Module II - Section 3

KuoOffice — Wed, 26 May 2010 13:01:45 -0700

Key Therapeutic Area: Anticoaugulation
http://pharmacogenomics.ucsd.edu/

Safe and Effective Medication Therapy Management

Module II - Section 2

KuoOffice — Wed, 26 May 2010 12:53:51 -0700

Key Therapeutic Area: Oncology
http://pharmacogenomics.ucsd.edu/

Safe and Effective Medication Therapy Management

Module II - Section 1

KuoOffice — Wed, 26 May 2010 12:51:01 -0700

Key Therapeutic Area: Infectious Disease
http://pharmacogenomics.ucsd.edu/

Safe and Effective Medication Therapy Management

Module I - Section 5

KuoOffice — Wed, 26 May 2010 10:59:44 -0700

Ethical Legal Social Issues
http://pharmacogenomics.ucsd.edu/

Safe and Effective Medication Therapy Management

Module I - Section 4

KuoOffice — Wed, 26 May 2010 10:56:12 -0700

Patient Case 2
http://pharmacogenomics.ucsd.edu/

Safe and Effective Medication Therapy Management

Module I - Section 3

KuoOffice — Wed, 26 May 2010 10:52:45 -0700

Patient Case 1
http://pharmacogenomics.ucsd.edu/

Safe and Effective Medication Therapy Management

Module I - Section 2

KuoOffice — Wed, 26 May 2010 10:47:55 -0700

Pharmacogenomic Nomenclature
http://pharmacogenomics.ucsd.edu/

Safe and Effective Medication Therapy Management

Module I - Section 1

KuoOffice — Wed, 26 May 2010 10:41:38 -0700

Translating Pharmacogenomic Into Practice
http://pharmacogenomics.ucsd.edu/

Safe and Effective Medication Therapy Management

A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration

KuoOffice — Wed, 21 Apr 2010 12:51:58 -0700

Age-related macular degeneration (AMD) is the most common cause of irreversible vision loss in the developed world and has a strong genetic predisposition. A locus at human chromosome 10q26 affects the risk of AMD, but the precise gene(s) have not been identified. We genotyped 581 AMD cases and 309 normal controls in a Caucasian cohort in Utah. We demonstrate that a single-nucleotide polymorphism, rs11200638, in the promoter region of HTRA1 is the most likely causal variant for AMD at 10q26 and is estimated to confer a population attributable risk of 49.3%.

Safe and Effective Medication Therapy Management

PharmGenEd™ Module I: Principles and Concepts

KuoOffice — Mon, 23 Nov 2009 13:55:59 -0800

Module I
The presentation is divided into several sections as outlined by the powerpoint slide. In this module we will include the basic concepts of pharmacogenomics, ethical, legal, social issues, and a brief introduction of the PharmGenEd program.

Please take a moment to fill out a CDC funded study survey about the program Click here

If you are a pharmacist seeking to obtain CPE credits Click here

Safe and Effective Medication Therapy Management

PharmGenEd: Clinical Application of Pharmacogenomics - Module II

KuoOffice — Wed, 18 Nov 2009 18:47:09 -0800

Module II:
Please take a moment to fill out a CDC funded study survey about the program Click here

If you are a pharmacist seeking to obtain CPE credits Click here

If you are a physician seeking to obtain CME credits Click here

Safe and Effective Medication Therapy Management

Pharmacogenomics Education Program Introduction

KuoOffice — Mon, 26 Oct 2009 13:04:02 -0700

PharmGenEd™: Bridging the Gap Between Science and Practice. This video provides a brief introduction about the CDC-funded pharmacogenomics education program, PharmGenEd(TM). The PharmGenEd faculty team at UCSD explains the different components about the program and the importance of learning pharmacogenomics information
Click here

Safe and Effective Medication Therapy Management

The Importance of Teaching Pharmacogenomics in Pharmacy and Medical Schools

KuoOffice — Mon, 26 Oct 2009 11:25:17 -0700

Pharmacogenomics relates to how genes control expression and structure of drug targets. Understanding pharmacogenomics and drug action are essential prerequisites for fulling mastering the concepts of this emerging discipline. Case examples of pharmacogenomic concepts is provided by Dr. Taylor.

Safe and Effective Medication Therapy Management

Pharmacogenomic Biomarkers for Prediction of Severe Adverse Drug Reactions

KuoOffice — Fri, 10 Apr 2009 11:23:22 -0700

Dr. Magnus Ingelman-Sundberg presents his recent paper on "Pharmacogenomic biomarkers for prediction of "severe adverse drug reactions" published in the New England Journal of Medicine on Feb 2008.

Safe and Effective Medication Therapy Management